Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04676152 · ClinicalTrials.gov registry record · NA
Validation of Noninvasive Blood Pressure Device
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT04676152 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 106 participants.
The verdict
NCT04676152, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
This is a prospective, nonrandomized multi-center study for the investigation of noninvasive sphygmomanometers. The purpose of the study is to validate the clinical performance of the Masimo noninvasive blood pressure device compared to reference auscultatory measurements.
Interventions
- DEVICE Masimo Noninvasive Blood Pressure Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2020-10-05 |
| Est. Completion | 2020-11-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04676152
The ClinicalTrials.gov registry entry for NCT04676152 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Masimo Noninvasive Blood Pressure Device is the first listed.
NCT04676152 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04676152 about?
NCT04676152 is a clinical study titled "Validation of Noninvasive Blood Pressure Device". This is a prospective, nonrandomized multi-center study for the investigation of noninvasive sphygmomanometers. The purpose of the study is to validate the clinical performance of the Masimo noninvasive blood pressure device compared to reference auscultatory measurements.
What is the current status of trial NCT04676152?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2020-10-05. Estimated completion is 2020-11-02.
What interventions are being tested in trial NCT04676152?
The interventions under investigation include: Masimo Noninvasive Blood Pressure Device (DEVICE).
Who is sponsoring clinical trial NCT04676152?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.